GLP-1s can support weight loss by helping you feel fuller for longer, slowing digestion, and reducing overall appetite
Caution is advised in patients with severe gastrointestinal disease, including severe gastroparesis
The evidence suggests that weight loss is the primary driver of the reproductive improvements seen with semaglutide, as substantial weight reduction is known to improve hormone balance, ovarian function and fertility in women with PMOS. Clare Thompson, MBBS, BSc, nMRCGP However, GLP-1 drugs may also have direct effects on reproductive health via mechanisms such as insulin signalling and ovarian function
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo
Maternal body mass index and pregnancy outcomes: a systematic review and metaanalysis
It helps your brain register fullness, and it supports how your body handles blood sugar